Virpax Pharmaceuticals Operating Income

Virpax Pharmaceuticals (VRPX) currently reports a operating income of $-12M as of December 2024. That compares with $-16M in the prior-year period — up 23.0% year over year. Use the charts on this page to explore Virpax Pharmaceuticals's operating income history and peer comparisons.

Virpax Pharmaceuticals's operating income increased from $-16M to $-12M — a 23.0% year-over-year increase (period ending December 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Virpax Pharmaceuticals reported $-12M in operating income as of December 2024. That compares with $-16M in the prior-year period — up 23.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-12M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Virpax Pharmaceuticals, and consider following VRPX for alerts when major investors trade the stock.

Virpax Pharmaceuticals is classified in the Healthcare sector. On operating income, it currently shows $-12M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VRPX with unrelated industries.